Rogaratinib Uses, Dosage, Side Effects and more
Rogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)).
| Trade Name | Rogaratinib |
| Generic | Rogaratinib |
| Rogaratinib Other Names | Rogaratinib |
| Type | |
| Formula | C23H26N6O3S |
| Weight | Average: 466.56 Monoisotopic: 466.178709895 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
